Terms: = Germ cell tumor AND FOXO3, FKHRL1, 2309, ENSG00000118689, MGC31925, MGC12739, FOXO2, FOXO3A, O43524, AF6q21, FKHRL1P2, DKFZp781A0677 AND Prognosis
20 results:
1. GNA13 inhibits glioblastoma metastasis via the ERKs/foxo3 signaling pathway.
Yi Q; Huang M; Zhang X; Xu Z; Sun J; Wang S; Xu H; Du Z; Liu M
Cell Signal; 2023 Sep; 109():110789. PubMed ID: 37392861
[TBL] [Abstract] [Full Text] [Related]
2. TNFSF13 Is a Novel Onco-Inflammatory Marker and Correlates With Immune Infiltration in Gliomas.
Chen R; Wang X; Dai Z; Wang Z; Wu W; Hu Z; Zhang X; Liu Z; Zhang H; Cheng Q
Front Immunol; 2021; 12():713757. PubMed ID: 34712225
[TBL] [Abstract] [Full Text] [Related]
3. Determination of hypoxia signature to predict prognosis and the tumor immune microenvironment in melanoma.
Shou Y; Yang L; Yang Y; Zhu X; Li F; Xu J
Mol Omics; 2021 Apr; 17(2):307-316. PubMed ID: 33624645
[TBL] [Abstract] [Full Text] [Related]
4. Diffuse Intrinsic Pontine Glioma (DIPG): Breakthrough and Clinical Perspective.
Perrone MG; Ruggiero A; Centonze A; Carrieri A; Ferorelli S; Scilimati A
Curr Med Chem; 2021; 28(17):3287-3317. PubMed ID: 32767913
[TBL] [Abstract] [Full Text] [Related]
5. foxo3a‑SIRT6 axis suppresses aerobic glycolysis in melanoma.
Dong Z; Yang J; Li L; Tan L; Shi P; Zhang J; Zhong X; Ge L; Wu Z; Cui H
Int J Oncol; 2020 Mar; 56(3):728-742. PubMed ID: 32124950
[TBL] [Abstract] [Full Text] [Related]
6. Circ-DONSON promotes malignant progression of glioma through modulating foxo3.
Zou Z; Dong YS; Liu JM; Zhao ZH; Li G; Liu DD
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):749-757. PubMed ID: 32016978
[TBL] [Abstract] [Full Text] [Related]
7. Valproic Acid Addresses Neuroendocrine Differentiation of LNCaP cells and Maintains cell Survival.
Giordano F; Naimo GD; Nigro A; Romeo F; Paolì A; De Amicis F; Vivacqua A; Morelli C; Mauro L; Panno ML
Drug Des Devel Ther; 2019; 13():4265-4274. PubMed ID: 31908413
[TBL] [Abstract] [Full Text] [Related]
8. MST1 suppresses viability and promotes apoptosis of glioma cells via upregulating SIRT6 expression.
Zhu D; Sun C; Qian X
J Integr Neurosci; 2019 Jun; 18(2):117-126. PubMed ID: 31321952
[TBL] [Abstract] [Full Text] [Related]
9. Transcriptional activation of SIRT6 via fkhrl1/foxo3a inhibits the Warburg effect in glioblastoma cells.
Dong Z; Zhong X; Lei Q; Chen F; Cui H
Cell Signal; 2019 Aug; 60():100-113. PubMed ID: 31004738
[TBL] [Abstract] [Full Text] [Related]
10. Gene expression profiles between cystic and solid vestibular schwannoma indicate susceptible molecules and pathways in the cystic formation of vestibular schwannoma.
Yan S; Wang Q; Huo Z; Yang T; Yin X; Wang Z; Zhang Z; Wu H
Funct Integr Genomics; 2019 Jul; 19(4):673-684. PubMed ID: 30953268
[TBL] [Abstract] [Full Text] [Related]
11. ALK positively regulates MYCN activity through repression of HBP1 expression.
Claeys S; Denecker G; Durinck K; Decaesteker B; Mus LM; Loontiens S; Vanhauwaert S; Althoff K; Wigerup C; Bexell D; Dolman E; Henrich KO; Wehrmann L; Westerhout EM; Demoulin JB; Kumps C; Van Maerken T; Laureys G; Van Neste C; De Wilde B; De Wever O; Westermann F; Versteeg R; Molenaar JJ; Påhlman S; Schulte JH; De Preter K; Speleman F
Oncogene; 2019 Apr; 38(15):2690-2705. PubMed ID: 30538293
[TBL] [Abstract] [Full Text] [Related]
12. foxo3-mediated chemo-protection in high-stage neuroblastoma depends on wild-type TP53 and SESN3.
Rupp M; Hagenbuchner J; Rass B; Fiegl H; Kiechl-Kohlendorfer U; Obexer P; Ausserlechner MJ
Oncogene; 2017 Nov; 36(44):6190-6203. PubMed ID: 28869600
[TBL] [Abstract] [Full Text] [Related]
13. Overexpression of foxo3a is associated with glioblastoma progression and predicts poor patient prognosis.
Qian Z; Ren L; Wu D; Yang X; Zhou Z; Nie Q; Jiang G; Xue S; Weng W; Qiu Y; Lin Y
Int J Cancer; 2017 Jun; 140(12):2792-2804. PubMed ID: 28295288
[TBL] [Abstract] [Full Text] [Related]
14. Elucidating the role of the foxo3a transcription factor in the IGF-1-induced migration and invasion of uveal melanoma cancer cells.
Yan F; Liao R; Farhan M; Wang T; Chen J; Wang Z; Little PJ; Zheng W
Biomed Pharmacother; 2016 Dec; 84():1538-1550. PubMed ID: 27881235
[TBL] [Abstract] [Full Text] [Related]
15. Nuclear foxo3 predicts adverse clinical outcome and promotes tumor angiogenesis in neuroblastoma.
Hagenbuchner J; Rupp M; Salvador C; Meister B; Kiechl-Kohlendorfer U; Müller T; Geiger K; Sergi C; Obexer P; Ausserlechner MJ
Oncotarget; 2016 Nov; 7(47):77591-77606. PubMed ID: 27769056
[TBL] [Abstract] [Full Text] [Related]
16. Bioinformatic profiling identifies an immune-related risk signature for glioblastoma.
Cheng W; Ren X; Zhang C; Cai J; Liu Y; Han S; Wu A
Neurology; 2016 Jun; 86(24):2226-34. PubMed ID: 27225222
[TBL] [Abstract] [Full Text] [Related]
17. Over-expression of CHAF1A promotes cell proliferation and apoptosis resistance in glioblastoma cells via AKT/foxo3a/Bim pathway.
Peng H; Du B; Jiang H; Gao J
Biochem Biophys Res Commun; 2016 Jan; 469(4):1111-6. PubMed ID: 26740175
[TBL] [Abstract] [Full Text] [Related]
18. An Analysis of Prognostic Factors in Patients with Ovarian Malignant germ cell tumors Who Are Treated with Fertility-Preserving Surgery.
Yang ZJ; Liu ZC; Wei RJ; Li L
Gynecol Obstet Invest; 2016; 81(1):1-9. PubMed ID: 25967958
[TBL] [Abstract] [Full Text] [Related]
19. Systemic approaches identify a garlic-derived chemical, Z-ajoene, as a glioblastoma multiforme cancer stem cell-specific targeting agent.
Jung Y; Park H; Zhao HY; Jeon R; Ryu JH; Kim WY
Mol Cells; 2014 Jul; 37(7):547-53. PubMed ID: 25078449
[TBL] [Abstract] [Full Text] [Related]
20. foxo3a is a major target of inactivation by PI3K/AKT signaling in aggressive neuroblastoma.
Santo EE; Stroeken P; Sluis PV; Koster J; Versteeg R; Westerhout EM
Cancer Res; 2013 Apr; 73(7):2189-98. PubMed ID: 23378341
[TBL] [Abstract] [Full Text] [Related]
